Debrisoquin (hydroiodide)
Debrisoquin (hydroiodide) is the hydrochloride form of Debrisoquin. Debrisoquin is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner. Debrisoquin can be used for antiviral research[1].
Product Specifications
CAS Number
1052540-65-4
Product Name Alternative
Debrisoquine (hydroiodide) ; Isocaramidine (hydroiodide) ; Ro 5-3307/1 (hydroiodide)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV; Ser/Thr Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/debrisoquin-hydroiodide.html
Concentration
10mM
Purity
99.84
Solubility
DMSO : 175 mg/mL (ultrasonic) |H2O : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N=C(N1CC2=C(CC1)C=CC=C2)N.I
Molecular Formula
C10H14IN3
Molecular Weight
303.15
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ANKRD44 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
α-Synuclein, Human, Recombinant, E.coli - Lyophilized
